SL
AVNS

Salomon & Ludwin’s Avanos Medical AVNS Stock Holding History

Salomon & Ludwin’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.6K Buy
2,049
+1,322
+182% +$17.8K ﹤0.01% 811
2025
Q4 		$8.22K Sell
727
-9
-1% -$103 ﹤0.01% 1556
2025
Q3 		$8.68K Buy
+736
New +$8.62K ﹤0.01% 1418

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Salomon & Ludwin's AVNS Position: Q1 2026 in Review

Salomon & Ludwin increased its Avanos Medical (AVNS) stake by 182% in Q1 2026, buying an estimated $17.8K and bringing the position to 2,049 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Salomon & Ludwin first reported a position in AVNS in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Salomon & Ludwin held 2,049 shares of Avanos Medical worth $28.6K as of Q1 2026.
  • Salomon & Ludwin bought 1,322 Avanos Medical shares in Q1 2026, an estimated $17.8K.
  • Avanos Medical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #811 holding.
  • Salomon & Ludwin first reported a position in Avanos Medical in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.